Evoq Remedies Limited

Recent announcements

• Corporate Insolvency Resolution Process (CIRP) - Admission of application by Tribunal11 Jun 2026 · Company Update / Admission of application by Tribunal
• Corporate Insolvency Resolution process (CIRP) - Admission of application by Tribunal10 Jun 2026 · Company Update / Admission of application by Tribunal
• Submission of Integrated Financial Results for the Half year and Year ended on 31st March, 202630 May 2026 · Company Update / General
• Appointment of Secretarial Auditor of the Company for FY 2025-26.30 May 2026 · Company Update / General
• Board of Directors has approved Audited Financials results for the Halh year and year ended on 31st March, 202630 May 2026 · Result / Financial Results
• Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. ....30 May 2026 · Board Meeting / Outcome of Board Meeting
• Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....27 May 2026 · Company Update / Board Meeting Rescheduled
• Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....11 May 2026 · Company Update / Board Meeting Rescheduled
• Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....7 May 2026 · Board Meeting / Board Meeting
• <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
• Compliances- Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• Intimation of Closure of Trading Window30 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
• Submission of certificate of Reg74(5) of SEBI (Depositories and participants) Regulations, 2018 for the Quarter ended on 31st December 20256 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel24 Oct 2025 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
• The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel23 Oct 2025 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
• The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Patel23 Oct 2025 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
• Integrated Filling (Finance)10 Oct 2025 · Company Update / General
• Financial Result fpr half year ended on 30th September 202510 Oct 2025 · Result / Financial Results
• Outcome of Board Meeting hel today i.e. 10th October 202510 Oct 2025 · Board Meeting / Outcome of Board Meeting
• Compliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 201810 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2025 ,inter alia, to consider and approve With reference to our earlier ....9 Oct 2025 · Company Update / Board Meeting Rescheduled
• Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 ,inter alia, to consider and approve Intimation of Board Meeting to ....3 Oct 2025 · Board Meeting / Board Meeting
• Intimation of the Closure of Trading Window30 Sep 2025 · Insider Trading / SAST / Closure of Trading Window
• Voting Results of the Annual General Meeting held on 17th September, 202519 Sep 2025 · AGM/EGM / AGM
• Scrutinizer Report of the Annual General Meeting of the Company held on 17th September, 2025.19 Sep 2025 · AGM/EGM / AGM
• Outcome and Summary of the Annual General Meeting held today i.e. 17th September, 2025.17 Sep 2025 · AGM/EGM / AGM
• Intimation of Book Closure26 Aug 2025 · Corp. Action / Book Closure
• Annual Report for the Financial Year 2024-2526 Aug 2025 · Others / Reg. 34 (1) Annual Report
• Intimation of the Annual General Meeting to be held on 17th September, 202526 Aug 2025 · AGM/EGM / AGM
• Outcome of the Board Meeting held on 26th August, 202526 Aug 2025 · Company Update / Appointment of Statutory Auditor/s
• Outcome of the Board Meeting held on 26th August, 2025.26 Aug 2025 · Others / Outcome without intimation
• Intimation for Withdrawal of proposed preferential issue.21 Aug 2025 · Company Update / General
• Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, at its meeting ....21 Aug 2025 · Others / Outcome without intimation
• Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 201814 Jul 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• Announcement under Regulation 30 (LODR) Resignation of Managing Director1 Aug 2024 · Company Update / Resignation of Managing Director
• Announcement under Regulation 30 (LODR) Appointment of Managing Director1 Aug 2024 · Company Update / Change in Directorate
• Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today ....1 Aug 2024 · Others / Outcome without intimation
• Intimation for Trading Approval received for Preferential Issue1 Aug 2024 · Company Update / Preferential Issue
• Submission of Certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulation, 2018 for the Quarter ended on 30th June 202413 Jul 2024 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• Submission of Revised Audited Financial Results for the Half year and Year Year ended on 31st March, 2024 along with Auditors Report12 Jul 2024 · Result / Financial Results